Register for OBR daily

To find out more about a company click on the company name to see a brief profile.

OBR Finance Top 5 Winners

AEZS $11.43 3.7500 +48.83%
KBIO $26.63 8.2300 +44.73%
OHRP $4.77 0.8000 +20.15%
CTIX $1.79 0.2190 +13.95%
DRNA $12.26 0.9800 +8.69%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

OBR Finance Top 5 Losers

NWBO $4.70 -0.2700 -5.43%
CYTK $11.71 -0.4000 -3.30%
VBLT $5.69 -0.1900 -3.23%
SRNE $8.41 -0.1700 -1.98%
XBIT $8.59 -0.1600 -1.83%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.

Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

<< First | < Prev | 877 | 878 | 879 | 880 | 881 | 882 | 883 | 884 | 885 | 886 | Next > | Last >>

After Cancer, Kids Get Too Many CT Scans: Study

(Reuters) June 14, 2012 - Children who have completed treatment for Hodgkin's lymphoma, a cancer of the lymph tissue, are routinely given follow-up CT scans that don't lead to better chances of surviving a relapse, according to a new study.
read article 

Which Doctor Does Your Colonoscopy May Matter

(Fox News/Reuters) June 15, 2012 - A new study adds to evidence that people who get screened for colon cancer are less likely to end up dying of the disease. But it matters what doctor performs the test, researchers found.
read article 

Genome-Wide Search May Provide Early-Warning System

(Bloomberg) June 14, 2012 - Screening the genomes of healthy people may give important clues about their cancer risk, according to a study that suggests advanced DNA technology might be employed early in a patient’s health assessment.
read article 

Analysis: Drug Costs Become Bigger Issue In Cancer Care

(Reuters) June 15, 2012 - In the past, money was no object when cancer specialists considered which drugs would provide the best treatment for their patients.
read article 

UK Cost Agency Rejects Roche's New Melanoma Pill

(Reuters) June 14, 2012 - Swiss group Roche's new melanoma drug Zelboraf has been rejected in a preliminary ruling by Britain's healthcare cost agency, triggering a fresh clash between the world's biggest maker of cancer drugs and NICE.
read article 

Myriad Genetics Gets Rights to Cancer-Linked Gene

(Yahoo! Finance/Associated Press) Jan 18, 2012 - Myriad Genetics Inc. said Wednesday that it has acquired the rights to a gene that, when mutated, is associated with increased risk for hereditary breast and ovarian cancer.
read article 

FDA Panel Backs Broader Use of Edwards Heart Valve

(Los Angeles Times/Associated Press) June 13, 2012 - A panel of heart experts said Wednesday that the government should expand approval of the first artificial heart valve designed to be implanted without major surgery, despite limited information about some long-term side effects.
read article (free registration required) 

CVS, Rite Aid Sue Pfizer Over Depression Drug

(Reuters) June 12, 2012 - CVS Caremark Corp and Rite Aid Corp filed an antitrust lawsuit accusing Pfizer Inc and Teva Pharmaceutical Industries Ltd of conspiring to keep generic versions of the popular antidepressant Effexor XR off store shelves.
read article 

Insight: Top Heart Doctors Fret Over New Blood Thinners

(Reuters) June 14, 2012 - For millions of heart patients, a pair of new blood thinners have been heralded as the first replacements in 60 years for warfarin, a pill whose hardships and risks have deterred many from using the stroke-prevention medicine.
read article 

Medicare Drug Discounts at Risk If Court Strikes Health Law

(Kaiser Health News) June 12, 2012 - Billions of dollars in drug savings for Medicare beneficiaries may come to an end if the Supreme Court overturns the 2010 federal health law, a drug industry spokesman said Tuesday.
read article 

$250,000 Warren Alpert Prize Goes to Researchers For Work on Blood Cancer Drug

(Boston Globe/White Coat Notes blog) June 13, 2012 - Harvard Medical School and the Warren Alpert Foundation announced Wednesday that an annual prize recognizing lab discoveries to advance human health will go to four scientists who developed the drug bortezomib used in treatment of multiple myeloma, a cancer of the blood.
read article (free registration required) 

Cancer Survivorship Conference Highlights Research For Survivor Care

(ACS) June 14, 2012 - More than 400 leading experts in cancer survivorship convened today for a conference, Cancer Survivorship Research: Translating Science to Care, to focus on such current concerns as how obesity might not have the same effects on all cancer survivors, and the substantial and increasing economic burden of cancer survivorship in the United States.
read press release 

Children’s Hospital of Pittsburgh of UPMC Chief Appointed President of the American Society of Pediatric Hematology/Oncology

(UPMC) June 14 – A. Kim Ritchey, M.D., chief, Division of Pediatric Hematology/Oncology, has been named president of the American Society of Pediatric Hematology/Oncology (ASPHO).
read press release 

Now Spray Tans Might Cause Cancer, Too

(New York Magazine) June 13, 2012 - Spray tanning has been touted as a "safe alternative" to basking in the sun or cooking in a UV bed, but now some say it's safe no more.
read article 

The Right to Choose Your Cancer Treatment

(New York Times/Well blog) June 13, 2012 - Before there was Betty Ford, the outspoken first lady who brought breast cancer awareness to the wider public, there was Babette Rosmond, a diminutive New York City writer and editor who went public with her diagnosis of breast cancer 40 years ago, three and a half years before the first lady.
read article 

Data and Safety Monitoring Board Recommends Continuation of Sunesis Pharmaceuticals' VALOR Trial Based on Periodic Safety Review

(Reuters) June 14, 2012 - Sunesis Pharmaceuticals, Inc. today announced that the independent Data and Safety Monitoring Board (DSMB) for the VALOR trial has completed a planned periodic safety review and recommended that the trial continue as planned without changes to study conduct.
read article 

Dendreon Shareholders Vent at Annual Meeting

(Xconomy Seattle) June 13, 2012 - Dendreon has had some triumphant annual meetings, where investors celebrated its work in creating the first FDA-approved drug that actively stimulates the immune system to fight cancer.
read article 

Great Strides Made in Developing New Medicines for Cancer

(Forbes) June 13, 2012 - While there has been a great deal of discussion around Obamacare and the Supreme Court ruling that is expected to be announced in the near future, much progress has been made in other areas of public health that has gone largely unnoticed.
read article 

Quest PharmaTech Initiates Phase II Oregovomab Front-Line Chemo-Immunotherapy Clinical Trial in United States

(Yahoo! Finance) June 14, 2012 - Quest PharmaTech Inc., a pharmaceutical company developing and commercializing products for the treatment of cancer, announces that it has received clearance from the United States Food and Drug Administration to initiate U.S. sites for an ongoing international Phase II clinical trial for oregovomab in advanced ovarian cancer patients.
read article 

Seattle Genetics Highlights Updated Survival Data from ADCETRIS® Pivotal Trial in Patients With Relapsed or Refractory Hodgkin Lymphoma

(TheStreet) June 14, 2012 - Seattle Genetics, Inc. today announced updated survival data from a pivotal clinical trial of single-agent ADCETRIS (brentuximab vedotin) in patients with relapsed or refractory Hodgkin lymphoma (HL) after autologous stem cell transplant (ASCT) showing that the median overall survival has not been reached after a 26.5 month median follow-up.
read article 

Whiff of Fresh News - Breath Test to Detect Lung and Breast Cancers

(RTT News) June 13, 2012 - When doctors and scientists attribute early detection of malignancies for an increased rate of survival in cancer affected individuals, there seems to be an ever-pressing need to devise methods that are less invasive, yet provide a comprehensive and successful detection of early cancer presence.
read article 

Targeted Radiation for Lung Cancer May Carry Risks

(U.S. News & World Report/HealthDay News) June 13, 2012 - A woman with early-stage lung cancer died recently after highly targeted radiation therapy zapped not just her tumor, but surrounding tissue, fatally damaging her airway.
read article 

Studies Unpick Why Bowel Cancers Become Resistant to Treatment

(Cancer Research UK/Press Association) June 13, 2012 - Bowel cancer cells develop resistance to new targeted cancer treatments by developing changes in a gene called KRAS, according to new research.
read article 

Common Cold Virus Attacks Cancer, Study Finds

(ABC News blog) June 13, 2012 - A virus that causes the common cold can also track and attack tumors, according to a new study that opens the door to novel cancer treatments.
read article 

New Report Estimates Nearly 18 Million Cancer Survivors in the U.S. by 2022

(ACS) June 14, 2012 - The number of Americans with a history of cancer, currently estimated to be 13.7 million, will grow to almost 18 million by 2022, according to a first-ever report by the American Cancer Society in collaboration with the National Cancer Institute (NCI).
read press release